Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study.
Bashorun AO, Kotei L, Jawla O, Jallow AF, Saidy AJ, Kinteh MA, Kujabi A, Jobarteh T, Kanu FJ, Donkor SA, Ezeani E, Fofana S, Njie M, Ceesay L, Jafri B, Williams A, Jeffries D, Kotanmi B, Mainou BA, Ooko M, Clarke E.
Bashorun AO, et al. Among authors: fofana s.
Lancet Infect Dis. 2024 Apr;24(4):417-426. doi: 10.1016/S1473-3099(23)00631-X. Epub 2024 Jan 15.
Lancet Infect Dis. 2024.
PMID: 38237616
Free PMC article.